Cutler Group LP Tg Therapeutics, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 3,000 shares of TGTX stock, worth $105,330. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,000

Previous 2,080 44.23%

Holding current value

$105,330

Previous $35,000 54.29%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$6.68 - $18.81 $18,169 - $51,163	-2,720 Reduced 56.67%	2,080 $35,000
Q3 2023 Nov 07, 2023	BUY	$8.36 - $26.5 $33,440 - $106,000	4,000 Added 500.0%	4,800 $40,000
Q2 2023 Jul 18, 2023	BUY	$15.48 - $35.0 $4,644 - $10,500	300 Added 60.0%	800 $19,000
Q2 2022 Aug 04, 2022	SELL	$3.74 - $10.66 $21,082 - $60,090	-5,637 Reduced 91.85%	500 $2,000
Q1 2022 Apr 14, 2022	BUY	$7.81 - $20.45 $36,839 - $96,462	4,717 Added 332.18%	6,137 $58,000
Q4 2021 Jan 18, 2022	SELL	$15.2 - $35.51 $42,864 - $100,138	-2,820 Reduced 66.51%	1,420 $26,000
Q3 2021 Oct 26, 2021	BUY	$21.78 - $40.45 $48,787 - $90,608	2,240 Added 112.0%	4,240 $141,000
Q2 2021 Jul 19, 2021	BUY	$32.5 - $48.96 $24,407 - $36,768	751 Added 60.13%	2,000 $77,000
Q4 2020 Jan 21, 2021	SELL	$25.27 - $54.9 $135,219 - $293,769	-5,351 Reduced 81.08%	1,249 $64,000
Q2 2020 Jul 22, 2020	BUY	$8.9 - $21.84 $58,348 - $143,183	6,556 Added 14900.0%	6,600 $128,000
Q4 2018 Feb 05, 2019	SELL	$3.44 - $5.76 $15,136 - $25,344	-4,400 Reduced 99.01%	44 $0
Q3 2018 Nov 07, 2018	BUY	$5.15 - $14.0 $22,660 - $61,600	4,400 Added 10000.0%	4,444 $24,000
Q2 2018 Aug 10, 2018	SELL	$12.5 - $15.0 $32,500 - $39,000	-2,600 Reduced 98.34%	44 $0
Q1 2018 May 11, 2018	SELL	$8.7 - $16.8 $15,503 - $29,937	-1,782 Reduced 40.26%	2,644 $37,000
Q4 2017 Jan 17, 2018	BUY	$7.35 - $12.3 $1,631 - $2,730	222 Added 5.28%	4,426 $36,000
Q3 2017 Oct 17, 2017	BUY	$10.0 - $12.7 $42,040 - $53,390	4,204	4,204 $49,000

Others Institutions Holding TGTX

# of Institutions

415

Shares Held

88.1M

Call Options Held

2.34M

Put Options Held

1.94M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.1B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account